Exchange: NASDAQ·Updated 12:36 PM EDT
TLSA logo

TLSATiziana Life Sciences Ltd

$0.9586
$0.0484
(5.32%)
Today
Reported EarningsMay 20
Mkt Cap$116.79M
Vol220,441.00
News
all
press releases
Tiziana Life Sciences Stock Rises Over 9% After Multiple Sclerosis Trial Enrollment Update
The biotechnology company has completed enrollment in its placebo-controlled study of intranasal foralumab, with late-stage data expected in 2026.
Stocktwits
More News
Wall Street Zen Downgrades Tiziana Life Sciences (NASDAQ:TLSA) to Sell
Wall Street Zen lowered Tiziana Life Sciences from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat
Tiziana Life Sciences (NASDAQ:TLSA) Trading 6.8% Higher - Here's What Happened
Tiziana Life Sciences (NASDAQ:TLSA) Trading 6.8% Higher - Here's What Happened...
MarketBeat
Tiziana Life Sciences Stock Jumps As Positive Preclinical Fuels Momentum
Tiziana Life Sciences shares jump on intranasal foralumab data, while technical indicators point to mixed momentum.read more...
Benzinga
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Down 4.4% - Should You Sell?
Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 4.4% - Should You Sell...
MarketBeat
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 0.7% - Here's What Happened
Tiziana Life Sciences (NASDAQ:TLSA) Shares Up 0.7% - Should You Buy...
MarketBeat
Tiziana Life Sciences (NASDAQ:TLSA) Stock Price Up 3.1% - Should You Buy?
Tiziana Life Sciences (NASDAQ:TLSA) Trading 3.1% Higher - Still a Buy...
MarketBeat
Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 7.4% - Still a Buy?
Tiziana Life Sciences (NASDAQ:TLSA) Shares Up 7.4% - What's Next...
MarketBeat
Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 4.4% - Here's Why
Tiziana Life Sciences (NASDAQ:TLSA) Shares Down 4.4% - Should You Sell...
MarketBeat
Tiziana Life Sciences (NASDAQ:TLSA) Shares Down 4.5% - Here's Why
Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 4.5% - Here's What Happened...
MarketBeat
<
1
2
>

Advertisement|Remove ads.